rs8386
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_080425.4(GNAS):c.3042C>T(p.Asn1014Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.02 in 1,613,866 control chromosomes in the GnomAD database, including 1,341 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.057 ( 633 hom., cov: 32)
Exomes 𝑓: 0.016 ( 708 hom. )
Consequence
GNAS
NM_080425.4 synonymous
NM_080425.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.08
Publications
28 publications found
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
GNAS Gene-Disease associations (from GenCC):
- McCune-Albright syndromeInheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- progressive osseous heteroplasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, NO_KNOWN Submitted by: G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- pseudohypoparathyroidism type 1BInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- pseudohypoparathyroidism type 1CInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- pseudopseudohypoparathyroidismInheritance: AD, Mitochondrial Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- pseudohypoparathyroidism type 1AInheritance: Mitochondrial, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 20-58910757-C-T is Benign according to our data. Variant chr20-58910757-C-T is described in ClinVar as Benign. ClinVar VariationId is 1166174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.08 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GNAS | NM_080425.4 | c.3042C>T | p.Asn1014Asn | synonymous_variant | Exon 13 of 13 | ENST00000371100.9 | NP_536350.2 | |
| GNAS | NM_000516.7 | c.1113C>T | p.Asn371Asn | synonymous_variant | Exon 13 of 13 | ENST00000371085.8 | NP_000507.1 | |
| GNAS | NM_016592.5 | c.*1019C>T | 3_prime_UTR_variant | Exon 13 of 13 | ENST00000371075.7 | NP_057676.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GNAS | ENST00000371100.9 | c.3042C>T | p.Asn1014Asn | synonymous_variant | Exon 13 of 13 | 5 | NM_080425.4 | ENSP00000360141.3 | ||
| GNAS | ENST00000371085.8 | c.1113C>T | p.Asn371Asn | synonymous_variant | Exon 13 of 13 | 1 | NM_000516.7 | ENSP00000360126.3 | ||
| GNAS | ENST00000676826.2 | c.3045C>T | p.Asn1015Asn | synonymous_variant | Exon 13 of 13 | ENSP00000504675.2 | ||||
| GNAS | ENST00000371102.8 | c.3000C>T | p.Asn1000Asn | synonymous_variant | Exon 12 of 12 | 5 | ENSP00000360143.4 | |||
| GNAS | ENST00000354359.12 | c.1116C>T | p.Asn372Asn | synonymous_variant | Exon 13 of 13 | 1 | ENSP00000346328.7 | |||
| GNAS | ENST00000371095.7 | c.1071C>T | p.Asn357Asn | synonymous_variant | Exon 12 of 12 | 1 | ENSP00000360136.3 | |||
| GNAS | ENST00000470512.6 | c.939C>T | p.Asn313Asn | synonymous_variant | Exon 13 of 13 | 5 | ENSP00000499552.2 | |||
| GNAS | ENST00000480232.6 | c.939C>T | p.Asn313Asn | synonymous_variant | Exon 14 of 14 | 5 | ENSP00000499545.2 | |||
| GNAS | ENST00000663479.2 | c.939C>T | p.Asn313Asn | synonymous_variant | Exon 13 of 13 | ENSP00000499353.2 | ||||
| GNAS | ENST00000462499.6 | c.894C>T | p.Asn298Asn | synonymous_variant | Exon 12 of 12 | 2 | ENSP00000499758.2 | |||
| GNAS | ENST00000467227.6 | c.894C>T | p.Asn298Asn | synonymous_variant | Exon 13 of 13 | 3 | ENSP00000499681.2 | |||
| GNAS | ENST00000478585.6 | c.894C>T | p.Asn298Asn | synonymous_variant | Exon 12 of 12 | 2 | ENSP00000499762.2 | |||
| GNAS | ENST00000481039.6 | c.894C>T | p.Asn298Asn | synonymous_variant | Exon 12 of 12 | 5 | ENSP00000499767.2 | |||
| GNAS | ENST00000485673.6 | c.894C>T | p.Asn298Asn | synonymous_variant | Exon 12 of 12 | 5 | ENSP00000499334.2 | |||
| GNAS | ENST00000488546.6 | c.894C>T | p.Asn298Asn | synonymous_variant | Exon 12 of 12 | 5 | ENSP00000499332.2 | |||
| GNAS | ENST00000492907.6 | c.894C>T | p.Asn298Asn | synonymous_variant | Exon 12 of 12 | 3 | ENSP00000499443.2 | |||
| GNAS | ENST00000371075.7 | c.*1019C>T | 3_prime_UTR_variant | Exon 13 of 13 | 1 | NM_016592.5 | ENSP00000360115.3 | |||
| GNAS | ENST00000453292.7 | c.*974C>T | 3_prime_UTR_variant | Exon 12 of 12 | 5 | ENSP00000392000.2 |
Frequencies
GnomAD3 genomes AF: 0.0568 AC: 8645AN: 152148Hom.: 633 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8645
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0218 AC: 5490AN: 251460 AF XY: 0.0189 show subpopulations
GnomAD2 exomes
AF:
AC:
5490
AN:
251460
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0162 AC: 23698AN: 1461600Hom.: 708 Cov.: 32 AF XY: 0.0157 AC XY: 11394AN XY: 727122 show subpopulations
GnomAD4 exome
AF:
AC:
23698
AN:
1461600
Hom.:
Cov.:
32
AF XY:
AC XY:
11394
AN XY:
727122
show subpopulations
African (AFR)
AF:
AC:
6038
AN:
33470
American (AMR)
AF:
AC:
689
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
555
AN:
26136
East Asian (EAS)
AF:
AC:
3
AN:
39694
South Asian (SAS)
AF:
AC:
936
AN:
86258
European-Finnish (FIN)
AF:
AC:
160
AN:
53420
Middle Eastern (MID)
AF:
AC:
211
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
13821
AN:
1111744
Other (OTH)
AF:
AC:
1285
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1207
2415
3622
4830
6037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
612
1224
1836
2448
3060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0568 AC: 8655AN: 152266Hom.: 633 Cov.: 32 AF XY: 0.0552 AC XY: 4113AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
8655
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
4113
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
7117
AN:
41520
American (AMR)
AF:
AC:
386
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
79
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5182
South Asian (SAS)
AF:
AC:
53
AN:
4824
European-Finnish (FIN)
AF:
AC:
41
AN:
10616
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
891
AN:
68032
Other (OTH)
AF:
AC:
75
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
391
782
1174
1565
1956
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
44
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.